Delivery Order SPE2DB25D3108-SPE2DB26FPBMM
Award Date 10/30/25
Potential Completion Date 10/31/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,870.86 and is scheduled for completion by July 31, 2025. The award represents a child contract action under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with a ceiling value of $22,473.32 and an ultimate completion date of October 31, 2025. This is a firm fixed price, non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This order, valued at $15,173.15 with a firm fixed price contract type, is scheduled for completion by September 29, 2025, and will be fulfilled from the company's Conshohocken, Pennsylvania location. The award was competitively procured with no set-aside designation and represents a delivery order against...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 6, 2025, valued at $5,664.59 for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials. This is a firm fixed-price delivery order with an ultimate completion date of June 9, 2025 and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation. This delivery order is issued under AmerisourceBergen...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $54,717.86 by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract is characterized as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and was competitively awarded with no set-aside designation. This award is a child contract issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on May 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication. The contract, valued at $1,566.65 with a firm fixed-price structure, is scheduled for completion by June 2, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with a contract ceiling value of $5,708.57 and an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials. The contract is valued at $15,565.13 with a firm fixed price structure and an ultimate completion date of October 31, 2025. This award represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with a contract ceiling value of $91,339.91. This is a firm fixed-price, non-competitive set-aside delivery order utilizing a competitive award process. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This delivery order falls...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 30, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a ceiling value of $28,295.68. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 31, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under...